PDS Biotechnology
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -15 | -15 | -15 | |
EBITDA | -6,444 | -7,859 | -7,284 | -8,722 |
EBIT | -6,450 | -7,289 | -8,727 | |
Net Income | -7,562 | -9,009 | -9,434 | -8,488 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,702 | -5,916 | -9,101 | -9,032 |
Cash | 26,711 | 26,198 | 31,873 | 39,978 |
Basic Shares | 46,384 | 46,869 | 45,902 | 40,521 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -60 | -59 | -57 | -49 |
EBITDA | -30,304 | -33,746 | -40,085 | -40,737 |
EBIT | -30,326 | -33,806 | -40,142 | -40,737 |
Net Income | -34,495 | -37,610 | -42,942 | -40,854 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 8,577 | |||
Free Cash Flow | -27,752,012 | -35,059 | -33,636 | -25,709 |
Cash | 26,711 | 41,689 | 56,560 | 73,820 |
Basic Shares | 46,384 | 36,453 | 30,952 | 28,599 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.14 |
2025-09-30 | -$0.19 |
2025-06-30 | -$0.21 |
